Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Cannabis and related products seller Tilray Brands (NASDAQ: TLRY ) is headquartered in Canada. However, the company seeks to expand its presence in the U.S. if/when cannabis is legally rescheduled there.

Is Tilray Stock Your Ticket to the Coming U.S. Cannabis Gold Rush?

Canopy Growth

SNDL Inc.

Canopy Growth has been bullish on marijuana legalization for years, and it recently got the OK to move ahead with Canopy USA. Tilray Brands has been expanding into the U.S. via alcohol brands and businesses.

Canopy Growth vs. SNDL vs. Tilray Brands: What's the Best Pot Stock to Buy If You're Bullish on Legalization?

Tilray's Canadian cannabis brand Redecan launches 'Purple Churro' – a sensational new flower offering making its debut in time for National Churro Day.

Redecan Cannabis Introduces New Top Shelf Flower 'Purple Churro'

Cronos Group

As the cannabis industry continues to grow, investors are closely watching top Canadian marijuana stocks this week. The global cannabis market is projected to reach $73.6 billion by 2027, with the U.S. market accounting for a significant portion. Recent news about potential federal legalization in the U.S. has fueled optimism. This could open up new opportunities for Canadian cannabis companies. With increasing demand for both medical and recreational cannabis, these companies are strategically positioned for growth. Investors should pay attention to market trends and developments. Using technical analysis can help identify buying opportunities and trends. Additionally, proper risk management is crucial to navigating this volatile market.

June 2024 Watchlist: Top Canadian Cannabis Stocks to Watch

Tickets Available Now and Through June 10th LITTLETON, Colo., June 04, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brew”), a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and 97.3 KBCO (iHeartMedia-Denver) are proud to announce the next On Tap with KBCO featuring live music at the Breckenridge Brewery in Littleton on August 10, 2024.

Breckenridge Brewery Announces 'On Tap with KBCO' Concert Series Featuring Gary Clark Jr.

Tilray Brands is a leading cannabis producer in Canada, but its growth prospects depend in large part on whether the U.S. will legalize pot in the near future. But even if that doesn't happen, odds are the business will continue to grow its operations via acquisitions.

Where Will Tilray Brands Be in 3 Years?

A company in Tilray Brands' marijuana portfolio just went bankrupt. Tilray now needs a new way to get exposure to the U.S. market.

1 New Reason to Consider Buying Tilray Brands Stock, and 1 New Reason to Sell

Aurora Cannabis

Marijuana stock investors are seeing the continued volatile action in the sector. There are more unknowns regarding reform and regulations that lead to more speculative trading. Still, the interest in finding the best marijuana stocks to buy comes into play. Investors want to be prepared for the next phase of the green rush in the market. What this could look like on the way to better trading is as follows. To start it's an election year and President Joe Biden has already voiced his support for cannabis reform.

Top Canadian Marijuana Stocks To Watch Right Now 2024

Marathon Digital Holdings

Plug Power

Meme stocks were big wealth creators for retail investors during the euphoric rally of 2021. Price-action in some stocks in the recent past might indicate that the meme stock season is returning.

3 Meme Stocks That Could Be Millionaire-Makers: May Edition

B2Gold

Transocean

Here are some penny stocks that could deliver massive returns on investment (ROI) for investors to consider as we move into the second quarter of this year. While these stocks are highly speculative, they can offer significant advantages and benefits for investors willing to embrace higher risk.

From Pennies to Profits: 3 Low-Priced Stocks Destined for Greatness

Tilray Brands is raising money through an at-the-market offering. The money is going to be used to fund acquisitions.

Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?

EVgo

Investing in penny stocks poses significant risks, as cautioned by the Securities & Exchange Commission. Penny stocks can have low volume, trade infrequently and be challenging to sell, potentially leading to a complete investment loss.

The Penny Stock Jackpot: 3 Hidden Gems to Uncover Before Wall Street Does

Curaleaf Holdings, Inc.

I have talked about cannabis stocks to buy in several instances in the last few quarters. However, the timing for exposure couldn't be better than now for several reasons.

Schedule III Windfall: 3 Stocks to Buy BEORE the Cannabis Reclassification

Tilray Brands won't be generating more cash than it spends this year. It had previously advised investors to expect the opposite.

Tilray Brands Slashed Its Guidance. Is the Stock a Buy?

Jazz Pharmaceuticals

Trulieve Cannabis Corp.

Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the status of cannabis stocks as a whole. Cannabis stocks, as a whole, spiked upwards on the news but quickly reverted to pre-announcement norms.

3 Cannabis Stocks to Buy Now: May 2024

Investors should not get overly excited about President Biden's decision to reclassify marijuana. The potential move toward becoming a less dangerous schedule 3 drug is lengthy and will not result in cannabis becoming federally legal.

Weed Out the Weak: 3 Choking Cannabis Stocks to Cut Now

Solei's New Cannabis-Infused Topical Solution is Made for Active Lifestyle Enthusiasts Solei's New Cannabis-Infused Topical Solution is Made for Active Lifestyle Enthusiasts

Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick'

IAMGOLD

Petco Health and Wellness

Penny stocks are a horrible investment. Selling for less than $1 per share, penny stocks are cheap for a reason.

The 3 Most Undervalued Penny Stocks to Buy in May 2024

Tilray Brands Inc. is getting ready for marijuana to be reclassified as a less dangerous drug in the U.S., as the cannabis company is looking to raise money through the sale of shares so it can expand.

Tilray to sell a large block of stock as it preps for cannabis reclassification

NEW YORK and LEAMINGTON, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY), a leading global lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”), under which it may offer and sell shares of its common stock (“Common Stock”) having an aggregate offering value of up to $250 million from time to time through an at-the-market equity program (“ATM Program”).

Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective

Riot Blockchain

The meme stock season seems to be back. Novavax (NASDAQ: NVAX ) has surged over 200% in the last month, with big gains coming in a few trading days.

3 Must-Buy Meme Stocks When Prices Plunge

Norwegian Cruise Line

Starbucks

Over the past 18 months, shares of online used car dealer Carvana (NASDAQ: CVNA ) staged a miraculous turnaround. Many expected to hear about a bankruptcy filing, not a rally.

Missed the 2,400% Run-Up in Carvana? 3 More Beaten-Down Stocks Ready to Zoom Higher

AdvisorShares Pure US Cannabis ETF

Cannabis stocks are once again on the move today, with some big names being seen across the sector. Shares of Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ), AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ), and Cronos (NASDAQ: CRON ) are all up between 2% and 10% in today's session, with Canopy Growth leading the way higher.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Green Thumb Industries Inc.

Innovative Industrial Properties

NewLake Capital Partners, Inc.

OrganiGram Holdings Inc.

Alex Carchidi is bullish on the cannabis sector but not ready to invest in stocks, except for Innovative Industrial Properties. 2 cannabis stocks worth considering are Green Thumb Industries and Trulieve Cannabis.

Looking For The Bud Light Of Cannabis

ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), one of the largest craft brewers in the Southeast and a subsidiary of Tilray Brands, Inc.  (NASDAQ: TLRY and TSX: TLRY), announced today the release of its new Sunset Sippin' Cocktail Inspired Hard Seltzers, crafted for a laid-back, tropical drinking experience. Sunset Sippers are available now throughout the Southeast and select national markets.

News for Tilray Brands Stock (TLRY)